Glaxosmith kline is conducting or will have conducted clinical trial studies of compound GW856553 to treat major depression.The study is in phase 2 clinical trials which means it should take another 5 years pending approval, before it hits the pharmacy shelves.Its truly promising to see active research going into treating depression.It is a disease often underdiagnosed and payed little attention too.Its about time to move on from fluoxetine(prozac) which has a host of side effects....
Check out the reference below if you are interested, they are currently recruiting research candidates to take part in the clinical trials.........
Stay well all....
Reference
http://clinicaltrials.gov/ct2/show/NCT00976560?term=NEW+DRUGS&rank=20
No comments:
Post a Comment